Qidong Li

7PUBLICATIONS
52CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2026
Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosis.

|Apr 08, 2026
DHODH-Mediated Suppression of Ferroptosis Supports Radioresistance and Represents a Therapeutic Vulnerability in Lung Cancer.

Chao Mao, Shengrong Wu, Girish H Rajacharya

|Jun 05, 2025
Disulfidptosis meets antitumour immunity.

Qidong Li, Boyi Gan

|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

Feiyu Chen, Haoyan Li, Yin Wang

|Mar 29, 2024
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers.

Guang Lei, Chao Mao, Amber D Horbath

|Mar 02, 2024
Proteomic analysis of ferroptosis pathways reveals a role of CEPT1 in suppressing ferroptosis.

Xiaoguang Liu, Zhen Chen, Yuelong Yan

Pageof 2

Frequent Collaborators

6 joint publications

Boyi Gan

3 joint publications

Yuelong Yan

3 joint publications

Chao Mao

2 joint publications

Mingchuang Sun